Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNFR:Fc in Segmental Allergen Challenge Model of Asthma
NCT00001893Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Aug 1999
- Primary completion
- Dec 2002
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in asthma, sponsored by National Heart, Lung, and Blood Institute. Started Aug 1999; status: completed.
02
Drugs
etanercept
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00001893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001893.